Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MECP2
|
ENSG00000169057.24 | methyl-CpG binding protein 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MECP2 | hg38_v1_chrX_-_154097731_154097746 | 0.45 | 1.1e-02 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.8 | GO:0035732 | nitric oxide storage(GO:0035732) |
1.2 | 4.9 | GO:0033606 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
1.0 | 4.0 | GO:0052255 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.9 | 2.8 | GO:2001037 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.9 | 3.6 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.9 | 3.5 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.9 | 1.7 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.8 | 2.5 | GO:0015734 | taurine transport(GO:0015734) |
0.8 | 5.0 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.8 | 6.5 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.8 | 2.3 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.8 | 2.3 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
0.8 | 3.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.7 | 2.2 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.7 | 5.6 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.7 | 1.4 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.7 | 2.1 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) chemorepulsion of branchiomotor axon(GO:0021793) |
0.7 | 2.8 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.7 | 2.6 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
0.7 | 2.6 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.6 | 2.6 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.6 | 4.4 | GO:0030421 | defecation(GO:0030421) |
0.6 | 4.9 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.6 | 1.8 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.6 | 2.9 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.6 | 2.9 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
0.6 | 1.7 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.6 | 5.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.6 | 2.2 | GO:0016334 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.6 | 1.7 | GO:2000412 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
0.5 | 0.5 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.5 | 1.6 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
0.5 | 2.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.5 | 4.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 1.0 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.5 | 1.5 | GO:0090031 | positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.5 | 5.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.5 | 2.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 0.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.5 | 1.5 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.5 | 0.5 | GO:0060928 | atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
0.5 | 1.4 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.5 | 1.9 | GO:0009956 | radial pattern formation(GO:0009956) |
0.5 | 3.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.5 | 3.2 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.5 | 1.4 | GO:0042946 | glucoside transport(GO:0042946) |
0.5 | 4.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.5 | 1.4 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.4 | 2.2 | GO:0002384 | hepatic immune response(GO:0002384) |
0.4 | 2.2 | GO:0032796 | uropod organization(GO:0032796) |
0.4 | 2.7 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
0.4 | 0.9 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.4 | 0.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.4 | 1.7 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
0.4 | 1.3 | GO:0048627 | myoblast development(GO:0048627) |
0.4 | 0.4 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.4 | 4.3 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.4 | 1.3 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.4 | 0.4 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 1.3 | GO:0098503 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) DNA 3' dephosphorylation(GO:0098503) DNA 3' dephosphorylation involved in DNA repair(GO:0098504) polynucleotide 3' dephosphorylation(GO:0098506) |
0.4 | 2.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 0.4 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.4 | 2.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.4 | 1.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.4 | 0.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.4 | 0.8 | GO:0045608 | inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) |
0.4 | 1.2 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.4 | 1.6 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.4 | 2.4 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.4 | 1.6 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.4 | 1.2 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
0.4 | 1.2 | GO:1904826 | regulation of phenotypic switching by transcription from RNA polymerase II promoter(GO:0100057) regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
0.4 | 1.2 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.4 | 2.4 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.4 | 1.6 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
0.4 | 0.4 | GO:1904868 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.4 | 1.2 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.4 | 1.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.4 | 1.5 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 1.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.4 | 2.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.4 | 0.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.4 | 2.6 | GO:1903786 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.4 | 1.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.4 | 0.7 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.4 | 0.4 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.4 | 1.8 | GO:0032848 | negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
0.4 | 0.7 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.4 | 0.7 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.4 | 2.5 | GO:0010816 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.4 | 2.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.4 | 3.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 0.3 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.3 | 1.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.3 | 1.4 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 1.7 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.3 | 5.5 | GO:2000828 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.3 | 4.5 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.3 | 1.0 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.3 | 1.0 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.3 | 0.7 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.3 | 1.0 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.3 | 5.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 1.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 1.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.3 | 1.0 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.3 | 1.0 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.3 | 1.0 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.3 | 5.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.3 | 1.3 | GO:1903400 | L-arginine transmembrane transport(GO:1903400) |
0.3 | 1.3 | GO:0052361 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.3 | 1.6 | GO:0033122 | negative regulation of cyclic nucleotide catabolic process(GO:0030806) negative regulation of cAMP catabolic process(GO:0030821) negative regulation of purine nucleotide catabolic process(GO:0033122) |
0.3 | 1.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 1.3 | GO:2000701 | parathyroid hormone secretion(GO:0035898) regulation of cell proliferation involved in mesonephros development(GO:2000606) negative regulation of cell proliferation involved in mesonephros development(GO:2000607) fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000699) glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000701) regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000702) negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000703) regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000733) negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000734) |
0.3 | 1.3 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.3 | 7.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 1.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 1.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.3 | 1.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.3 | 0.6 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.3 | 0.3 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.3 | 0.9 | GO:0035445 | borate transmembrane transport(GO:0035445) borate transport(GO:0046713) |
0.3 | 1.3 | GO:0061443 | endocardial cushion cell differentiation(GO:0061443) |
0.3 | 0.9 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 1.6 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.3 | 1.3 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
0.3 | 1.9 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.3 | 1.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.3 | 0.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.3 | 1.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.3 | 1.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.3 | 1.8 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 1.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 0.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.3 | 0.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.3 | 0.9 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.3 | 0.9 | GO:1903464 | negative regulation of mitotic cell cycle DNA replication(GO:1903464) |
0.3 | 0.3 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.3 | 3.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.3 | 2.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.3 | 4.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.3 | 1.5 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 1.8 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.3 | 1.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 1.2 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.3 | 0.9 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.3 | 1.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 1.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 1.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.3 | 0.3 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.3 | 0.6 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.3 | 1.1 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.3 | 0.3 | GO:2000452 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.3 | 0.3 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 0.8 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.3 | 1.1 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.3 | 1.7 | GO:0035624 | receptor transactivation(GO:0035624) |
0.3 | 0.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.3 | 0.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.3 | 0.6 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.3 | 1.7 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.3 | 1.4 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.3 | 1.7 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.3 | 1.4 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
0.3 | 1.9 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.3 | 0.8 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.3 | 1.7 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.3 | 0.8 | GO:1900098 | epithelial cell differentiation involved in salivary gland development(GO:0060690) epithelial cell maturation involved in salivary gland development(GO:0060691) regulation of plasma cell differentiation(GO:1900098) positive regulation of plasma cell differentiation(GO:1900100) positive regulation of lactation(GO:1903489) |
0.3 | 2.7 | GO:0001705 | ectoderm formation(GO:0001705) |
0.3 | 0.5 | GO:0070662 | mast cell proliferation(GO:0070662) |
0.3 | 1.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.3 | 1.6 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.3 | 0.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.3 | 1.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.3 | 0.8 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
0.3 | 1.3 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.3 | 2.1 | GO:0045007 | depurination(GO:0045007) |
0.3 | 1.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.3 | 11.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.3 | 4.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 1.3 | GO:0036233 | glycine import(GO:0036233) |
0.3 | 1.8 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.3 | 1.8 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.3 | 1.6 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.3 | 1.0 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
0.3 | 1.0 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.3 | 1.0 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 4.7 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.3 | 0.3 | GO:1904640 | response to methionine(GO:1904640) |
0.3 | 2.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 1.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.3 | 0.3 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.3 | 0.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.3 | 0.8 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.3 | 1.0 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.3 | 0.8 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
0.3 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.3 | 1.0 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 0.5 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.3 | 1.5 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.3 | 1.0 | GO:0014011 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.2 | 1.5 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.2 | 1.2 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.2 | 1.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.2 | 2.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 2.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.2 | 2.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.2 | 0.5 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
0.2 | 0.2 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.2 | 1.7 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.2 | 2.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.5 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 0.7 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
0.2 | 1.0 | GO:1904782 | negative regulation of glutamate receptor signaling pathway(GO:1900450) negative regulation of NMDA glutamate receptor activity(GO:1904782) |
0.2 | 0.2 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.2 | 0.7 | GO:0045897 | positive regulation of transcription during mitosis(GO:0045897) |
0.2 | 1.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.7 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.2 | 0.7 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 5.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 1.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.2 | 0.7 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.2 | 0.7 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.2 | 0.2 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
0.2 | 1.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.2 | 1.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 3.0 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 2.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 1.4 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.2 | 0.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.5 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 0.2 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
0.2 | 1.1 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.2 | 0.9 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
0.2 | 0.7 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.2 | 0.5 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.2 | 0.7 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.2 | 0.2 | GO:0031657 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031657) |
0.2 | 0.7 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.2 | 28.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 0.7 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
0.2 | 0.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.2 | 0.2 | GO:2000506 | negative regulation of energy homeostasis(GO:2000506) |
0.2 | 0.4 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
0.2 | 2.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 2.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.7 | GO:1902598 | creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
0.2 | 1.1 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.2 | 0.9 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.2 | 15.9 | GO:0035924 | cellular response to vascular endothelial growth factor stimulus(GO:0035924) |
0.2 | 2.6 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.2 | 2.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.6 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.2 | 0.6 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
0.2 | 0.4 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.2 | 0.4 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 0.6 | GO:0090108 | positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
0.2 | 1.9 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.2 | 1.7 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.2 | GO:0061197 | fungiform papilla morphogenesis(GO:0061197) |
0.2 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 1.3 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.2 | 2.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.4 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.2 | 1.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 0.8 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.2 | 0.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.2 | 1.0 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.2 | 0.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 1.0 | GO:0044209 | AMP salvage(GO:0044209) |
0.2 | 0.4 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.2 | 0.8 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.2 | 0.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.4 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 1.0 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.2 | 1.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.2 | 1.2 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 1.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 1.6 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 3.2 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 1.4 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
0.2 | 1.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.2 | 2.0 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.2 | 0.8 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.2 | 1.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 0.6 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 2.5 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.2 | 0.6 | GO:0060345 | spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.2 | 0.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.2 | 0.4 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.2 | 2.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.2 | 1.2 | GO:2000984 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.2 | 0.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.2 | 0.6 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.2 | 1.3 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
0.2 | 1.0 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.2 | 1.0 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.2 | 1.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.2 | 1.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 4.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.2 | 0.6 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.2 | 1.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 7.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.2 | 2.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.2 | 0.9 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.2 | 0.7 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.2 | 0.6 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.2 | 0.9 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.2 | 0.4 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.2 | 0.9 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.2 | 1.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.2 | 0.9 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.2 | 0.9 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 3.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 0.9 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.2 | 1.5 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
0.2 | 0.7 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.2 | 0.2 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.2 | 0.7 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
0.2 | 0.9 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 0.5 | GO:0040033 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 0.4 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.2 | 1.8 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.2 | 0.5 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.2 | 0.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.2 | 0.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 2.0 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.2 | 0.5 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.9 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.2 | 0.5 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 1.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.5 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.2 | 3.9 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.2 | 0.5 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.2 | 0.4 | GO:0036492 | regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.2 | 0.9 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.5 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.2 | 1.1 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.2 | 0.5 | GO:0034059 | response to anoxia(GO:0034059) |
0.2 | 1.0 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.2 | 0.9 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 0.5 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
0.2 | 1.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 0.5 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.2 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.5 | GO:1901874 | negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 0.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 0.2 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 2.1 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.2 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 2.2 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.2 | 0.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.2 | 0.7 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.2 | 0.5 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 1.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 1.4 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.2 | 1.0 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.2 | 0.7 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
0.2 | 0.7 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.5 | GO:0000349 | generation of catalytic spliceosome for first transesterification step(GO:0000349) |
0.2 | 1.5 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.2 | 1.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 0.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.2 | 3.9 | GO:0098780 | response to mitochondrial depolarisation(GO:0098780) |
0.2 | 1.2 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 1.2 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.2 | 4.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 1.0 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 1.0 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.2 | 0.2 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.2 | 3.5 | GO:0009299 | mRNA transcription(GO:0009299) |
0.2 | 0.3 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 0.2 | GO:0018307 | enzyme active site formation(GO:0018307) |
0.2 | 1.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.2 | 4.5 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 1.3 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.2 | 0.2 | GO:0099542 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
0.2 | 1.3 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 1.2 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.2 | 1.1 | GO:0072364 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter(GO:0072364) |
0.2 | 0.8 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.2 | 1.5 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.2 | 0.5 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
0.2 | 0.5 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.2 | 0.5 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.5 | GO:0010931 | macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
0.2 | 0.8 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.2 | 4.0 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.2 | 0.6 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.2 | 0.6 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.2 | 0.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.2 | 0.5 | GO:0090270 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.2 | 1.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.2 | 6.7 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.5 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 0.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 0.2 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.2 | 0.6 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.2 | 0.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.3 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 0.3 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.2 | 1.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 1.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 1.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 1.3 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 0.5 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 2.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.2 | 0.5 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.2 | 0.8 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 0.5 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.2 | 0.5 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.2 | 0.2 | GO:1904387 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
0.2 | 1.1 | GO:0051012 | microtubule sliding(GO:0051012) |
0.2 | 0.6 | GO:1903949 | positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
0.2 | 0.6 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.2 | 4.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.2 | 0.2 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.2 | 0.5 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 1.2 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.3 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.2 | 0.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 0.2 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.2 | 0.5 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.2 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 1.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 1.5 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.1 | 0.6 | GO:0051413 | response to cortisone(GO:0051413) |
0.1 | 0.7 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 1.2 | GO:1902739 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 2.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 2.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.9 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 2.8 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 0.6 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.1 | 0.3 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.6 | GO:0045355 | negative regulation of interferon-alpha biosynthetic process(GO:0045355) |
0.1 | 0.3 | GO:1904179 | regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
0.1 | 0.4 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.1 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.3 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
0.1 | 1.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 2.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.4 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 0.6 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.1 | 0.7 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.1 | 0.7 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 2.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.1 | GO:2000627 | regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.1 | 0.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 1.0 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 0.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.9 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 1.4 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.4 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.1 | 0.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 1.1 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.4 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.1 | 2.0 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 2.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.1 | 0.4 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.1 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 1.7 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.1 | 0.4 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.1 | 2.5 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.4 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 0.4 | GO:1903911 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of receptor clustering(GO:1903911) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 1.9 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.4 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 2.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 1.9 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.1 | 0.7 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 1.1 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 2.0 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.1 | 0.3 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.1 | 3.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 2.4 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.4 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.1 | 1.1 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
0.1 | 0.8 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.5 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 2.5 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 0.4 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
0.1 | 2.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.3 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
0.1 | 1.7 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.1 | 0.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.1 | 0.3 | GO:0061643 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
0.1 | 1.7 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.7 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.1 | 2.2 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
0.1 | 0.5 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.8 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.1 | 2.0 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
0.1 | 1.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.1 | 3.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 3.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.5 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.1 | 0.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.1 | 0.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 7.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 0.9 | GO:0031622 | positive regulation of fever generation(GO:0031622) |
0.1 | 1.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 1.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.8 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.4 | GO:1903576 | response to L-arginine(GO:1903576) |
0.1 | 0.3 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 3.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.8 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 1.8 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.1 | 0.1 | GO:0061438 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
0.1 | 1.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.4 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
0.1 | 0.5 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.1 | 1.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 1.3 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 0.3 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.1 | 0.6 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 1.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 2.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 0.4 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.1 | 0.6 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.1 | 2.4 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
0.1 | 1.0 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.1 | 0.1 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 1.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.5 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.2 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.1 | 1.7 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 3.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.1 | 3.5 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.5 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.1 | 1.0 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 1.0 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.1 | 0.4 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
0.1 | 0.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.6 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.1 | 4.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 1.9 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 1.1 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.1 | 1.4 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 0.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.1 | 0.5 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.1 | 1.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 0.1 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.1 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 1.3 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 1.4 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.7 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 1.5 | GO:0045820 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 3.9 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 2.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.6 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.1 | 0.4 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.1 | 2.1 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.1 | 0.2 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 2.6 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.6 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.1 | 0.2 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.1 | 0.5 | GO:0042348 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.1 | 1.3 | GO:0048539 | bone marrow development(GO:0048539) |
0.1 | 1.2 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.1 | 1.0 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
0.1 | 0.2 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 2.1 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.3 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.1 | 0.2 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.1 | 1.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.8 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.3 | GO:0099550 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signalling, modulating synaptic transmission(GO:0099550) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.1 | 1.3 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.1 | 1.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 0.5 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 1.0 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 1.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.7 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.5 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.1 | 0.8 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.3 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.1 | 0.6 | GO:1902164 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.1 | 1.4 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 1.1 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 3.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.5 | GO:0043366 | beta selection(GO:0043366) |
0.1 | 2.1 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.1 | 0.6 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 1.8 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.1 | 0.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 0.9 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.4 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
0.1 | 0.3 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 1.7 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
0.1 | 0.6 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
0.1 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.1 | 1.7 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.1 | 2.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.2 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.4 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.7 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.1 | 0.3 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.4 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.1 | 1.7 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 2.0 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 3.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.1 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 1.2 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 1.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 1.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.3 | GO:0006043 | glucosamine catabolic process(GO:0006043) |
0.1 | 0.8 | GO:2001268 | urokinase plasminogen activator signaling pathway(GO:0038195) negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.1 | 3.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.1 | 0.6 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.1 | 0.3 | GO:0005989 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.1 | 0.5 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 3.5 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
0.1 | 0.3 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
0.1 | 2.3 | GO:0097205 | renal filtration(GO:0097205) |
0.1 | 0.2 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 0.9 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 1.0 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 1.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.1 | 0.3 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.1 | 0.6 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 2.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 5.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.1 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.1 | 0.7 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 0.9 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
0.1 | 0.7 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.1 | 1.5 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.3 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.1 | 5.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.3 | GO:0052248 | induction of programmed cell death(GO:0012502) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) positive regulation of apoptotic process in other organism(GO:0044533) modulation by symbiont of host programmed cell death(GO:0052040) positive regulation by symbiont of host programmed cell death(GO:0052042) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.1 | 0.7 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.1 | 0.6 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 0.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.1 | 2.1 | GO:2000303 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.5 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.9 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.1 | 0.5 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.1 | 1.6 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 1.2 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 1.3 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.1 | 7.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.2 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.1 | 0.1 | GO:0000393 | generation of catalytic spliceosome for second transesterification step(GO:0000350) spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.1 | 0.4 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.1 | 0.6 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.1 | 1.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.5 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.1 | 0.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.1 | 0.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 2.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.8 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 1.9 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 1.3 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 3.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 0.7 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 1.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 1.0 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 0.9 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
0.1 | 1.3 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
0.1 | 0.8 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) negative regulation of podosome assembly(GO:0071802) |
0.1 | 2.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 4.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 0.1 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.1 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 1.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 1.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.1 | 0.5 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.7 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 0.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.1 | 0.4 | GO:0009305 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.1 | 0.8 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.1 | 2.3 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 0.9 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.3 | GO:0009644 | response to high light intensity(GO:0009644) |
0.1 | 0.7 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.1 | 0.2 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.1 | 0.4 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
0.1 | 1.4 | GO:0051608 | histamine transport(GO:0051608) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 5.6 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.1 | 0.3 | GO:0010260 | organ senescence(GO:0010260) |
0.1 | 2.3 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 0.4 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 1.0 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.1 | 0.7 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 2.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.4 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.7 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.1 | 0.6 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 5.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 1.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 2.0 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.1 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.1 | 0.7 | GO:0071569 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.4 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.1 | 0.7 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.1 | 0.9 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.1 | 2.8 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.6 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.3 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 6.7 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 1.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.6 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
0.1 | 1.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.1 | 0.3 | GO:2001311 | lysobisphosphatidic acid metabolic process(GO:2001311) |
0.1 | 0.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.3 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.1 | 1.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 1.9 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 1.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.5 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.1 | 1.9 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 1.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.5 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.4 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.1 | 1.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 1.2 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 1.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 1.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 6.8 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.1 | 0.2 | GO:0031393 | negative regulation of prostaglandin biosynthetic process(GO:0031393) |
0.1 | 1.2 | GO:0051645 | Golgi localization(GO:0051645) |
0.1 | 2.4 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.1 | 1.1 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.4 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.1 | 2.2 | GO:0007567 | parturition(GO:0007567) |
0.1 | 3.0 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 1.1 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.9 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) |
0.1 | 1.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.4 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.1 | 0.6 | GO:0080009 | mRNA methylation(GO:0080009) |
0.1 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 0.3 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 0.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 3.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.3 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.3 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 3.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 0.2 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
0.1 | 1.1 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 0.2 | GO:0051796 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of transforming growth factor beta2 production(GO:0032912) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.1 | 0.8 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.1 | 0.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 1.1 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.5 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.5 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.7 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.4 | GO:0043382 | positive regulation of T-helper 1 type immune response(GO:0002827) interleukin-23-mediated signaling pathway(GO:0038155) positive regulation of memory T cell differentiation(GO:0043382) positive regulation of T-helper 17 cell differentiation(GO:2000321) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.1 | 0.2 | GO:0098583 | mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
0.1 | 1.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.1 | 0.3 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.1 | 3.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.6 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.1 | 0.5 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.1 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.9 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.1 | 1.3 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 1.6 | GO:0051412 | response to corticosterone(GO:0051412) |
0.1 | 0.6 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.8 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.1 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 0.2 | GO:0019075 | virus maturation(GO:0019075) |
0.1 | 0.2 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.9 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.2 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.1 | 0.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 1.9 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.1 | 1.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 1.4 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.1 | 0.5 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.3 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.1 | 1.8 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.1 | 0.5 | GO:0051958 | methotrexate transport(GO:0051958) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 1.9 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.1 | 0.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 1.5 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 0.2 | GO:2000758 | positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.1 | 0.3 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.4 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.6 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.1 | 1.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0070895 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
0.1 | 0.4 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.1 | 0.8 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.1 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine salvage(GO:0071267) |
0.1 | 1.2 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.1 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.9 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.1 | 1.2 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.3 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.1 | 0.4 | GO:0006574 | valine catabolic process(GO:0006574) |
0.1 | 0.6 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
0.1 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.1 | 2.5 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.1 | 0.9 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.2 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.1 | 1.4 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
0.1 | 1.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 1.0 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.1 | 0.9 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.1 | 0.9 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.1 | 0.4 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 1.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 1.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 1.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 1.0 | GO:0038202 | TORC1 signaling(GO:0038202) |
0.1 | 0.2 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.1 | 0.3 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.1 | 0.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.1 | 0.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
0.1 | 0.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.2 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.1 | 1.0 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 0.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.1 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.1 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.1 | 1.0 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.1 | 0.3 | GO:0097646 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.1 | 0.2 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 3.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.2 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
0.1 | 0.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.1 | 0.8 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.1 | 0.1 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.1 | 0.1 | GO:0048880 | sensory system development(GO:0048880) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.1 | 0.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.1 | 1.1 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 1.0 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 3.1 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.1 | 1.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.5 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.2 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.1 | 0.7 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 0.5 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.1 | 0.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.5 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.1 | 1.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 5.4 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.1 | 0.3 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.7 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.1 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.4 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
0.1 | 0.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 0.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.4 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.1 | 0.3 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.1 | 2.0 | GO:0033006 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.1 | 3.0 | GO:0097178 | ruffle assembly(GO:0097178) |
0.1 | 0.3 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.1 | 4.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.1 | 1.6 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.3 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.1 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 1.3 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.1 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
0.1 | 0.3 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.2 | GO:0014735 | regulation of muscle atrophy(GO:0014735) negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.1 | 1.9 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.7 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 0.6 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.1 | 0.2 | GO:0070317 | regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 6.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.9 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
0.1 | 0.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 1.0 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 3.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.1 | 0.2 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.1 | 0.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.3 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 0.4 | GO:0018032 | protein amidation(GO:0018032) |
0.1 | 0.2 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.1 | 0.4 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.1 | 0.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 0.9 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.1 | 0.1 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.1 | 0.3 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.1 | 1.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 0.9 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.3 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.1 | 0.2 | GO:0010269 | response to selenium ion(GO:0010269) |
0.1 | 1.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 1.0 | GO:0000154 | rRNA modification(GO:0000154) |
0.1 | 0.5 | GO:0038061 | NIK/NF-kappaB signaling(GO:0038061) |
0.1 | 2.4 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
0.1 | 1.0 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.3 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.8 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.2 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.1 | 1.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.1 | 1.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.2 | GO:0060309 | elastin catabolic process(GO:0060309) |
0.1 | 0.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.1 | 1.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 4.0 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.2 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.1 | 0.4 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.1 | 1.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.8 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.3 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.1 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.2 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
0.1 | 0.2 | GO:0006463 | steroid hormone receptor complex assembly(GO:0006463) |
0.1 | 0.2 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.1 | 0.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.1 | 0.3 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.1 | 1.8 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 2.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.3 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 0.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.1 | 0.1 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.5 | GO:0050703 | interleukin-1 alpha production(GO:0032610) interleukin-1 alpha secretion(GO:0050703) |
0.1 | 0.4 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.1 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.1 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.1 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.1 | 1.3 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.9 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.2 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.1 | 0.2 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.6 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.4 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 0.3 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 0.2 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.1 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 1.1 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.1 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.9 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.1 | 1.1 | GO:0006751 | glutathione catabolic process(GO:0006751) |
0.1 | 0.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.9 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 0.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 0.2 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
0.1 | 0.4 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.4 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.0 | 0.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.0 | GO:0006272 | leading strand elongation(GO:0006272) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.8 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.3 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.0 | 0.8 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:0035932 | renin-angiotensin regulation of aldosterone production(GO:0002018) mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
0.0 | 0.7 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.3 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.0 | 0.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.0 | 0.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.0 | 0.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.0 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.0 | 0.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.3 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.0 | 0.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.9 | GO:0097034 | mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 1.5 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.0 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0032917 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.0 | 0.0 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 24.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.1 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
0.0 | 7.7 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 0.3 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.0 | 0.4 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
0.0 | 0.3 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.0 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.0 | 0.4 | GO:0090239 | regulation of histone H4 acetylation(GO:0090239) |
0.0 | 0.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.0 | 1.4 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.2 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.0 | 0.8 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
0.0 | 0.7 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.0 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.4 | GO:0071379 | cellular response to prostaglandin stimulus(GO:0071379) |
0.0 | 0.4 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.1 | GO:0018194 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.0 | 0.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.4 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.0 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.0 | 1.2 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 2.3 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.6 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.0 | 0.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.0 | 0.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.0 | 0.7 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.2 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.0 | 0.1 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.0 | 0.7 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 3.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.0 | 0.7 | GO:0030878 | thyroid gland development(GO:0030878) |
0.0 | 0.2 | GO:0070293 | renal absorption(GO:0070293) |
0.0 | 0.0 | GO:0008291 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.0 | 0.0 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
0.0 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.0 | 1.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.0 | 0.1 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.0 | 0.2 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 0.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.1 | GO:0060914 | heart formation(GO:0060914) |
0.0 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.0 | 1.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.2 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.0 | 0.7 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.3 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 1.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.0 | 0.6 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.0 | 0.1 | GO:1990172 | G-protein coupled receptor catabolic process(GO:1990172) |
0.0 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.3 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 2.2 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.0 | 0.4 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.0 | 1.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 3.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.6 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.3 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.1 | GO:1902416 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) |
0.0 | 1.6 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.4 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.0 | 0.3 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 0.3 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.1 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.0 | 0.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.0 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.7 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
0.0 | 0.1 | GO:0035853 | chromosome passenger complex localization to spindle midzone(GO:0035853) |
0.0 | 0.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) positive regulation of gastro-intestinal system smooth muscle contraction(GO:1904306) |
0.0 | 0.2 | GO:0015677 | copper ion import(GO:0015677) |
0.0 | 0.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.2 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.0 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.2 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.0 | 0.1 | GO:1902161 | transepithelial water transport(GO:0035377) regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.0 | 2.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.5 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.0 | 0.6 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.0 | 0.0 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.0 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.0 | 0.3 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.3 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.2 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.0 | 0.2 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
0.0 | 1.0 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 0.1 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.0 | 0.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
0.0 | 0.1 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 0.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.1 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.0 | 0.1 | GO:1903961 | positive regulation of anion channel activity(GO:1901529) positive regulation of anion transmembrane transport(GO:1903961) |
0.0 | 0.1 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 2.2 | GO:0010324 | membrane invagination(GO:0010324) |
0.0 | 0.4 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
0.0 | 0.3 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.5 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.1 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.0 | 0.6 | GO:0014904 | myotube cell development(GO:0014904) |
0.0 | 0.3 | GO:0097435 | fibril organization(GO:0097435) |
0.0 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 2.0 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.0 | 0.5 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.1 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.1 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.0 | 6.2 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.2 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.0 | 0.1 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.1 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.0 | 0.5 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.2 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
0.0 | 0.9 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 1.6 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.0 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.0 | 0.1 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.1 | GO:0018008 | N-terminal protein myristoylation(GO:0006499) N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
0.0 | 0.4 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.0 | 0.1 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.0 | 0.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 | 0.7 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.0 | 0.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 1.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.1 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.0 | 1.3 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.2 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.0 | 0.3 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.0 | 0.1 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.0 | 0.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.0 | 0.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
0.0 | 0.2 | GO:0033146 | regulation of intracellular estrogen receptor signaling pathway(GO:0033146) |
0.0 | 0.4 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.4 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.0 | 0.2 | GO:0033753 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.0 | 0.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.0 | 0.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.0 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.1 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.0 | 0.0 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.0 | 0.1 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.0 | 0.6 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.1 | GO:0034205 | beta-amyloid formation(GO:0034205) regulation of beta-amyloid formation(GO:1902003) |
0.0 | 0.1 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.0 | 0.0 | GO:0090308 | maintenance of DNA methylation(GO:0010216) regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.1 | GO:0098751 | bone cell development(GO:0098751) |
0.0 | 0.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.0 | 0.1 | GO:0009085 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
0.0 | 0.2 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.0 | 0.1 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0002158 | osteoclast proliferation(GO:0002158) |
0.0 | 0.1 | GO:0061709 | reticulophagy(GO:0061709) |
0.0 | 0.1 | GO:0046636 | negative regulation of alpha-beta T cell activation(GO:0046636) |
0.0 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.0 | 0.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.4 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.0 | 0.0 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.0 | 0.0 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.0 | 0.1 | GO:0002837 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of response to tumor cell(GO:0002834) positive regulation of response to tumor cell(GO:0002836) regulation of immune response to tumor cell(GO:0002837) positive regulation of immune response to tumor cell(GO:0002839) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.1 | GO:0009651 | response to salt stress(GO:0009651) |
0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 0.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.2 | GO:0097576 | vacuole fusion(GO:0097576) |
0.0 | 0.1 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.0 | 0.1 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.2 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.1 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.1 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.1 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.0 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.0 | 0.2 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.0 | 0.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.0 | 0.0 | GO:1902594 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
0.0 | 0.8 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.0 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.0 | 0.3 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.0 | 0.0 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
0.0 | 0.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.0 | 2.0 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.2 | GO:2000727 | positive regulation of cardiac muscle cell differentiation(GO:2000727) |
0.0 | 0.1 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.0 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.9 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.1 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.5 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.0 | 0.1 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.1 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.1 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.0 | 0.0 | GO:0032801 | receptor catabolic process(GO:0032801) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:0060987 | lipid tube(GO:0060987) |
1.3 | 3.9 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.2 | 5.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.6 | 1.7 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.5 | 2.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.5 | 2.6 | GO:0045160 | myosin I complex(GO:0045160) |
0.5 | 3.1 | GO:0044753 | amphisome(GO:0044753) |
0.5 | 1.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.5 | 5.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.4 | 2.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.4 | 1.3 | GO:0044609 | DBIRD complex(GO:0044609) |
0.4 | 1.7 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.4 | 3.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.4 | 1.6 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.4 | 1.6 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.4 | 3.6 | GO:0035976 | AP1 complex(GO:0035976) |
0.4 | 0.7 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.4 | 5.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.4 | 2.5 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.3 | 1.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.3 | 2.4 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.3 | 6.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 3.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 0.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 1.0 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
0.3 | 1.0 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.3 | 4.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 1.0 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.3 | 1.6 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.3 | 1.9 | GO:0071746 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.3 | 2.5 | GO:0031415 | NatA complex(GO:0031415) |
0.3 | 0.3 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.3 | 1.6 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 0.3 | GO:1903349 | omegasome membrane(GO:1903349) |
0.3 | 2.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.3 | 3.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 1.2 | GO:0033167 | ARC complex(GO:0033167) |
0.3 | 4.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.3 | 1.2 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.3 | 2.3 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 6.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 1.4 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.3 | 1.4 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.3 | 0.8 | GO:0031251 | PAN complex(GO:0031251) |
0.3 | 3.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 1.9 | GO:0072589 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.3 | 5.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 2.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.3 | 4.0 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 1.0 | GO:0002133 | polycystin complex(GO:0002133) |
0.3 | 2.1 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.3 | 0.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.3 | 5.1 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.3 | 0.8 | GO:0030689 | Noc complex(GO:0030689) |
0.2 | 0.5 | GO:0031905 | early endosome lumen(GO:0031905) |
0.2 | 1.0 | GO:1990879 | CST complex(GO:1990879) |
0.2 | 26.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 0.7 | GO:0031085 | BLOC-3 complex(GO:0031085) |
0.2 | 0.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 1.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 2.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 2.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 0.9 | GO:0039713 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.2 | 1.5 | GO:0034448 | EGO complex(GO:0034448) |
0.2 | 0.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 1.7 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.2 | 3.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.6 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.2 | 1.7 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.2 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 5.9 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.2 | 0.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 2.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.2 | 7.3 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.2 | 2.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 1.2 | GO:1990032 | parallel fiber(GO:1990032) |
0.2 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 0.8 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.2 | 0.6 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.2 | 0.8 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 2.5 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 1.3 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 1.0 | GO:0036501 | UFD1-NPL4 complex(GO:0036501) |
0.2 | 0.8 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 15.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 2.2 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 3.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.5 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.2 | 5.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.4 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.2 | 0.7 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.2 | 0.7 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.2 | 1.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 1.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.2 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 1.4 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 0.5 | GO:0000805 | X chromosome(GO:0000805) |
0.2 | 2.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.5 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 1.2 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 0.5 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.2 | 0.5 | GO:0070685 | macropinocytic cup(GO:0070685) |
0.2 | 5.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 1.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 2.8 | GO:0030897 | HOPS complex(GO:0030897) |
0.2 | 0.2 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.2 | 2.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 2.1 | GO:0097413 | Lewy body(GO:0097413) |
0.2 | 3.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 2.1 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.2 | 2.1 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 1.3 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 1.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 1.3 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.2 | 2.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 3.5 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 1.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 2.1 | GO:0032059 | bleb(GO:0032059) |
0.2 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 1.3 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 1.4 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.2 | 0.8 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 2.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 11.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.3 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.1 | 3.0 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 1.2 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 0.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 1.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 2.6 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.2 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 0.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 1.3 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.4 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.4 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 1.9 | GO:0030686 | 90S preribosome(GO:0030686) |
0.1 | 0.4 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.1 | 0.5 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.4 | GO:1990597 | Ire1 complex(GO:1990332) AIP1-IRE1 complex(GO:1990597) |
0.1 | 1.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.5 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 0.4 | GO:0036284 | tubulobulbar complex(GO:0036284) |
0.1 | 0.5 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.1 | 1.7 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.3 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 0.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 2.1 | GO:0031932 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.1 | 1.7 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.1 | 1.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 2.0 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.9 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 1.2 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 1.6 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 1.0 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 8.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 1.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 3.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 4.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 2.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 1.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 0.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 1.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 2.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 2.0 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 3.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 0.8 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 1.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.3 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
0.1 | 0.5 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.1 | 2.0 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.1 | 3.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 1.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.1 | GO:0070993 | translation preinitiation complex(GO:0070993) |
0.1 | 1.6 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.1 | 0.3 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) integral component of lysosomal membrane(GO:1905103) |
0.1 | 0.1 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.3 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 4.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.3 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.1 | 15.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 1.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.1 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 3.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.9 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 1.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 1.8 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.3 | GO:0034455 | t-UTP complex(GO:0034455) |
0.1 | 1.7 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 2.0 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 4.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 1.0 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 3.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.1 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 1.3 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.8 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.1 | 0.5 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
0.1 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.8 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 1.8 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.4 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.1 | 0.6 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 0.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.7 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 1.0 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 2.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.5 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.1 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 0.5 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.1 | 5.7 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.8 | GO:0030891 | VCB complex(GO:0030891) |
0.1 | 1.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 2.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 2.9 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.8 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.6 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 2.4 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 15.6 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 1.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
0.1 | 8.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 0.6 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 9.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 0.6 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 0.9 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 2.2 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 0.9 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.2 | GO:0014802 | terminal cisterna(GO:0014802) |
0.1 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.2 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 0.5 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 4.9 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.3 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.3 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 12.6 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 3.0 | GO:0097346 | INO80-type complex(GO:0097346) |
0.1 | 3.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 1.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 0.3 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 1.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.4 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.1 | 0.2 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 0.4 | GO:0045293 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.1 | 1.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 0.4 | GO:0019012 | virion(GO:0019012) virion part(GO:0044423) |
0.1 | 1.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 0.4 | GO:0008623 | CHRAC(GO:0008623) |
0.1 | 0.8 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.1 | 0.9 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 0.2 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.1 | 0.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 1.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 6.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 1.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.5 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.5 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.8 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 1.1 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.6 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 0.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 2.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 2.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 0.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 2.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.3 | GO:0035363 | histone locus body(GO:0035363) |
0.1 | 0.4 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 3.2 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 3.8 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 3.6 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 8.1 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 3.4 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 0.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 6.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 1.1 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 1.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 0.3 | GO:0005712 | chiasma(GO:0005712) |
0.1 | 0.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 2.9 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.1 | 0.2 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 1.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 6.3 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 18.4 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 0.4 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 0.3 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.9 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.2 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.0 | 0.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.0 | 3.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 1.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.5 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.8 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.0 | 0.7 | GO:0098553 | integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.0 | 0.2 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.3 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.0 | 4.6 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 2.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.0 | 0.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 1.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.0 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 3.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 1.8 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 2.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 13.5 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 1.5 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) zymogen granule membrane(GO:0042589) |
0.0 | 0.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 4.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 2.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.0 | 0.4 | GO:0072487 | MSL complex(GO:0072487) |
0.0 | 0.0 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.2 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.0 | 1.3 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.2 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.9 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 2.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0032116 | SMC loading complex(GO:0032116) |
0.0 | 18.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 1.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 12.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.0 | 0.3 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.0 | 0.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.0 | 0.3 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 2.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.5 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 1.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 2.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 8.6 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.5 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 4.1 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 2.0 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 6.0 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 4.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.4 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 1.0 | GO:0035579 | specific granule membrane(GO:0035579) |
0.0 | 0.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 3.9 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 4.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 2.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0090651 | apical cytoplasm(GO:0090651) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.5 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 0.5 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.0 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.0 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.0 | 0.0 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.0 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 50.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 2.4 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 1.8 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.6 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.0 | 5.8 | GO:0005730 | nucleolus(GO:0005730) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.8 | GO:0035731 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
1.2 | 4.8 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
0.9 | 3.8 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
0.9 | 3.8 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.9 | 2.7 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
0.8 | 2.5 | GO:0005368 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
0.8 | 2.3 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.7 | 2.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.7 | 3.6 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.7 | 3.6 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.7 | 2.7 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.7 | 3.3 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.6 | 5.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.6 | 1.8 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.6 | 1.8 | GO:0005055 | laminin receptor activity(GO:0005055) |
0.6 | 2.2 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.5 | 2.6 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.5 | 1.5 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
0.5 | 2.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 2.9 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.5 | 0.5 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.5 | 1.4 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.5 | 1.4 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
0.5 | 5.9 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 2.7 | GO:0039552 | RIG-I binding(GO:0039552) |
0.5 | 1.4 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
0.4 | 2.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.4 | 3.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 1.3 | GO:0017129 | triglyceride binding(GO:0017129) |
0.4 | 3.0 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.4 | 1.3 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
0.4 | 1.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.4 | 4.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.4 | 2.1 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.4 | 2.1 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.4 | 2.1 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.4 | 1.6 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.4 | 5.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 2.4 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.4 | 1.2 | GO:0016419 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
0.4 | 2.4 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.4 | 1.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.4 | 1.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.4 | 0.4 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.4 | 1.1 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.4 | 5.6 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.4 | 1.8 | GO:0004803 | transposase activity(GO:0004803) |
0.4 | 3.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.4 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.4 | 2.5 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.4 | 1.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.4 | 1.1 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.3 | 1.0 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
0.3 | 0.3 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.3 | 1.4 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.3 | 1.4 | GO:0045569 | TRAIL binding(GO:0045569) |
0.3 | 0.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.3 | 1.7 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 1.0 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.3 | 1.6 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.3 | 0.7 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.3 | 1.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 1.0 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.3 | 0.6 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.3 | 1.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.3 | 1.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 0.9 | GO:0046715 | borate transmembrane transporter activity(GO:0046715) |
0.3 | 0.6 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.3 | 1.9 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 0.9 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.3 | 2.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.3 | 1.5 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 2.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.3 | 0.9 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.3 | 2.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 0.9 | GO:0008903 | hydroxypyruvate isomerase activity(GO:0008903) |
0.3 | 4.0 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.3 | 2.6 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.3 | 1.4 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.3 | 0.8 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.3 | 2.0 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.3 | 3.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.3 | 1.1 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.3 | 0.8 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
0.3 | 5.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 2.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.3 | 1.0 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.3 | 2.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.3 | 2.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 0.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.3 | 2.3 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.3 | 1.0 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.3 | 2.6 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 1.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.3 | 2.6 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 3.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 2.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.3 | 4.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.3 | 1.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 2.3 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 2.2 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.2 | 2.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 1.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.2 | 1.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 2.2 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.2 | 1.5 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 0.7 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
0.2 | 0.7 | GO:0004958 | prostaglandin F receptor activity(GO:0004958) |
0.2 | 1.2 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 0.7 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.2 | 2.2 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 0.2 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
0.2 | 0.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 1.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 1.9 | GO:0046979 | TAP2 binding(GO:0046979) |
0.2 | 0.7 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.9 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.2 | 0.2 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
0.2 | 0.9 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.2 | 1.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 1.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 0.4 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.2 | 0.7 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
0.2 | 4.8 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 0.9 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.2 | 0.7 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.2 | 6.6 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 1.1 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.2 | 17.3 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.6 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
0.2 | 0.6 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.2 | 0.6 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.2 | 1.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 0.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 0.6 | GO:0008650 | rRNA (uridine-2'-O-)-methyltransferase activity(GO:0008650) rRNA (uridine) methyltransferase activity(GO:0016436) |
0.2 | 2.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.2 | 1.3 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.6 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.2 | 0.4 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.2 | 1.2 | GO:0031692 | alpha-1B adrenergic receptor binding(GO:0031692) |
0.2 | 6.4 | GO:0048156 | tau protein binding(GO:0048156) |
0.2 | 2.9 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 1.4 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 1.0 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.2 | 2.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 2.6 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.2 | 1.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 1.8 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.6 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.2 | 0.6 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 1.8 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 2.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 2.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.2 | 0.6 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
0.2 | 0.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 0.6 | GO:0097689 | iron channel activity(GO:0097689) |
0.2 | 0.8 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.2 | 1.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.2 | 0.2 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.2 | 2.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 1.3 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.2 | 2.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 1.0 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.2 | 6.1 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 3.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 1.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.2 | 0.6 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.2 | 6.0 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 1.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 1.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 1.5 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 0.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.2 | 0.6 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.2 | 1.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 2.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 0.7 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.2 | 1.6 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.2 | 1.6 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 5.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 1.4 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.2 | 3.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 0.5 | GO:0042008 | interleukin-18 receptor activity(GO:0042008) |
0.2 | 0.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.2 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.5 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 1.1 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.2 | 3.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.2 | 0.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.5 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.2 | 2.6 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.2 | 1.2 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 3.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.7 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.7 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.2 | 2.0 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.2 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 2.7 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.2 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 2.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 0.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.2 | 0.3 | GO:0032427 | GBD domain binding(GO:0032427) |
0.2 | 1.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.2 | 1.5 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.7 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 3.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 5.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.2 | 1.5 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.7 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.2 | 4.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 1.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.2 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 2.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.2 | 0.8 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.2 | 0.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.2 | 1.9 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.2 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.2 | 0.5 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.2 | 4.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.9 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.2 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.2 | 0.5 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 0.3 | GO:0015923 | mannosidase activity(GO:0015923) |
0.2 | 1.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.2 | 4.6 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.6 | GO:0004644 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) |
0.2 | 6.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.2 | 1.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.5 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
0.2 | 0.6 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
0.2 | 2.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 1.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 1.2 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.1 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 0.4 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.1 | 0.7 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 1.5 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.1 | 1.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 1.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 0.4 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.1 | 1.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 1.9 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.9 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
0.1 | 3.0 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.3 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 1.9 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 2.9 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 1.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.6 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 6.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 1.1 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 1.1 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 1.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.1 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
0.1 | 0.4 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.1 | 2.2 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
0.1 | 1.4 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 0.3 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 1.5 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 2.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
0.1 | 0.5 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 6.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 3.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 4.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 2.9 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 0.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 0.7 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.4 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 5.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 1.0 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.5 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 1.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.8 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 3.9 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.4 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.6 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 0.8 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.1 | 0.3 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.1 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.6 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 3.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 3.6 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.6 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 2.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.4 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
0.1 | 0.6 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
0.1 | 3.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 24.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 2.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 1.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 3.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 1.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.8 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.2 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.1 | 0.3 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.1 | 0.9 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 2.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 0.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.8 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 2.2 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.3 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.1 | 2.5 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 1.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.1 | 0.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.7 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 5.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 6.7 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 1.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 2.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 1.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.8 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 5.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.1 | 0.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 9.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 3.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 0.4 | GO:0047291 | neolactotetraosylceramide alpha-2,3-sialyltransferase activity(GO:0004513) lactosylceramide alpha-2,3-sialyltransferase activity(GO:0047291) |
0.1 | 0.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.5 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 1.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.1 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
0.1 | 0.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.1 | 1.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 0.3 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.1 | 3.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 2.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 1.6 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 0.7 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.2 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 1.4 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 5.9 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 4.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 2.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 1.0 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 1.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.3 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 1.6 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.1 | 0.1 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.1 | 0.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.4 | GO:0004077 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.1 | 2.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.6 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.1 | 0.6 | GO:0015094 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.1 | 0.2 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 0.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.4 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.1 | 2.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 1.3 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.3 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 4.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 1.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 0.5 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 1.1 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.3 | GO:0019948 | SUMO activating enzyme activity(GO:0019948) |
0.1 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.8 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.1 | 0.7 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.3 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.1 | 0.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 2.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 1.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0070363 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial light strand promoter sense binding(GO:0070363) mitochondrial heavy strand promoter sense binding(GO:0070364) |
0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.4 | GO:0046527 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) glucosyltransferase activity(GO:0046527) |
0.1 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 2.3 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 1.4 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.8 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.8 | GO:0005497 | androgen binding(GO:0005497) |
0.1 | 2.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 5.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 0.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 1.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 1.0 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.1 | 1.6 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.3 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 2.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 1.0 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.9 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 1.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 2.9 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 0.5 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.1 | 0.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 0.2 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 0.3 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 1.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.4 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.1 | 0.5 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.2 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.1 | 0.2 | GO:0015055 | secretin receptor activity(GO:0015055) |
0.1 | 0.5 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.1 | 0.5 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 4.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.2 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.4 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 0.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 2.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 0.1 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.1 | 0.2 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.1 | 0.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 3.6 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 2.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.5 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.1 | 1.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 1.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.2 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.1 | 0.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.1 | 0.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.2 | GO:0047708 | biotinidase activity(GO:0047708) |
0.1 | 0.3 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.1 | 1.4 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 2.6 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 2.8 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.6 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.1 | 1.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 2.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.7 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 1.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.7 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 0.3 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 52.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 1.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 1.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.2 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.1 | 0.2 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.1 | 0.2 | GO:0061599 | nitrate reductase activity(GO:0008940) molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.1 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 1.4 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.3 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 1.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.9 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.2 | GO:0052858 | peptidyl-lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0052858) |
0.1 | 0.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.2 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.1 | 10.9 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.1 | 2.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.3 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.1 | 0.5 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.3 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.1 | 0.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.1 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 2.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.1 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.3 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.1 | 0.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.2 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 2.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.6 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 1.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 0.4 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.1 | 0.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.1 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.2 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 1.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 2.5 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 1.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 0.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 1.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.2 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
0.1 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
0.1 | 1.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 1.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 1.5 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 2.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.5 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 0.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 5.1 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 0.4 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.1 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 12.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 0.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.5 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 4.9 | GO:0001618 | virus receptor activity(GO:0001618) |
0.1 | 0.3 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 3.7 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 1.4 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.4 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.2 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.1 | 1.7 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 1.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 1.4 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.8 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 1.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.5 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 3.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.0 | 0.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.0 | 1.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 1.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 2.7 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 1.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 1.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.6 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 2.8 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.0 | 0.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.0 | 0.4 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 1.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.1 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
0.0 | 2.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 5.5 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.2 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.0 | 0.1 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.0 | 0.5 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0090422 | thiamine pyrophosphate transporter activity(GO:0090422) |
0.0 | 0.3 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.4 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
0.0 | 0.2 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
0.0 | 0.1 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.0 | 0.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.0 | 0.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.9 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.0 | 0.2 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.0 | 0.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 0.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.0 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 1.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.0 | 0.1 | GO:0047750 | cholestenol delta-isomerase activity(GO:0047750) |
0.0 | 0.8 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.2 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.0 | 0.8 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.2 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.0 | 0.6 | GO:0034452 | dynactin binding(GO:0034452) |
0.0 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 3.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.4 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 1.2 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.6 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.0 | 0.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 0.3 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 1.3 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.0 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) hepoxilin-epoxide hydrolase activity(GO:0047977) |
0.0 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 7.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 2.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.0 | 1.1 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.6 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.0 | 0.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.0 | 0.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.2 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
0.0 | 8.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 1.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.0 | 0.0 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.2 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.0 | 0.3 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
0.0 | 1.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 1.1 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.3 | GO:0051920 | thioredoxin peroxidase activity(GO:0008379) peroxiredoxin activity(GO:0051920) |
0.0 | 0.1 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.0 | 1.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 0.6 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.0 | 1.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.4 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.1 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.1 | GO:0005139 | interleukin-7 receptor binding(GO:0005139) |
0.0 | 0.3 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.0 | 0.2 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.0 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 2.3 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.9 | GO:0071617 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.1 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.0 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.0 | 0.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.0 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.1 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.0 | 7.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 1.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.0 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.0 | 0.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.0 | 1.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.0 | 0.1 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.0 | 1.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 1.3 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.0 | 6.0 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 1.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.1 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.0 | 0.1 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.1 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.0 | 0.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 3.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.1 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0032183 | SUMO binding(GO:0032183) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.5 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 0.1 | GO:0032093 | SAM domain binding(GO:0032093) |
0.0 | 2.3 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 3.2 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 0.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.7 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.0 | 0.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 2.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 39.2 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0048495 | Roundabout binding(GO:0048495) |
0.0 | 0.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.0 | 0.2 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.4 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.6 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.0 | 0.1 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.0 | 0.2 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.0 | 1.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.1 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.0 | 0.0 | GO:0019781 | NEDD8 activating enzyme activity(GO:0019781) |
0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 0.1 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.2 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.0 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
0.0 | 0.1 | GO:0072349 | sulfur amino acid transmembrane transporter activity(GO:0000099) modified amino acid transmembrane transporter activity(GO:0072349) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.0 | 0.0 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.0 | 0.7 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.3 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 6.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.3 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 1.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 7.1 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 5.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.3 | 0.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 2.0 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.2 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 0.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.2 | 0.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.2 | 10.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 14.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 14.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 17.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 3.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 2.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.2 | 0.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 5.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 16.6 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 2.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 2.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 5.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 7.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 11.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 20.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 11.5 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 1.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 3.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 5.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 9.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 8.9 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 5.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 5.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 10.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 2.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 11.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 8.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 9.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 3.3 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 6.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 4.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 2.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 3.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.2 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 3.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 3.3 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 2.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 2.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 13.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 4.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 4.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 5.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 1.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 2.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.1 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.1 | 5.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 3.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.9 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 2.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 1.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 2.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 2.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 12.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 3.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 2.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 3.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 2.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 3.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 2.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.3 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.8 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 9.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 1.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 1.4 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 1.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 1.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 0.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 3.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.1 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.4 | 1.6 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 4.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 3.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 9.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 6.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 5.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.3 | 6.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.3 | 40.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 8.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 2.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 11.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 0.4 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.2 | 5.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 3.7 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.2 | 2.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 2.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 7.6 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 1.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 3.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.2 | 8.8 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.2 | 3.0 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 1.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 0.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 2.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.2 | 3.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 4.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 2.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 5.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.2 | 3.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 3.7 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 3.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 6.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 3.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.7 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.9 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 3.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.8 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 2.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 6.8 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 5.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 8.0 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.5 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 2.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 21.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 13.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 8.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.1 | 5.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 1.0 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.1 | 2.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 3.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 3.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 6.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 4.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 4.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 1.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.5 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 3.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 1.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 2.9 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 4.4 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 5.2 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 4.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.2 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 0.9 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 4.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 7.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 4.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 1.9 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 6.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 9.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 3.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 6.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 4.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 6.0 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 4.2 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.1 | 1.9 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 3.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 1.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.1 | 0.9 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 4.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.8 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
0.1 | 3.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 5.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 3.6 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 3.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 1.6 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.9 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 1.1 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 1.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 7.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 4.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 2.7 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 1.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.0 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.1 | 1.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.5 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 22.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 1.5 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 0.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.3 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 1.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 1.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 3.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.2 | REACTOME ACTIVATED TLR4 SIGNALLING | Genes involved in Activated TLR4 signalling |
0.0 | 6.1 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.0 | 0.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 1.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 1.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 2.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 1.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 1.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 1.3 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.0 | 4.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.5 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 1.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 3.7 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 2.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 1.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.4 | REACTOME POL SWITCHING | Genes involved in Polymerase switching |
0.0 | 0.3 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.3 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.5 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 0.6 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.0 | 0.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 1.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.9 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.5 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 1.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.4 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 1.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.1 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.7 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 1.0 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.2 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.0 | 0.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |